Stock listing
Munich:NV40 Cellectar Biosciences, Inc. Aktie
German listing (Munich) of Cellectar Biosciences, Inc. · home listing NASDAQ:CLRB
Follow Cellectar Biosciences, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:CLRB
$1.21 USD -0.01 (-1.2%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CLRB
- Day range
- $1.18 – $1.21 USDOct 30, 2026
- Volume
- 55,282 sharesOct 30, 2026
- Market cap
- $11.39M USDAt the close on Oct 30, 2026 · price × 9.45M shares outstanding
- 52-week range
- $1.12 – $4.70 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $145,038 USDMedian day 53,167 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CLRB · Home | $1.205 USD | -0.015 (-1.2%) | 55,282 | $1.205 | $1.205 | $1.18 | $1.22 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:CLRB · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.205 | -0.015 | -1.2% | $1.205 | $1.205 | $1.18 | 55,282 | |
| $1.22 | -0.02 | -1.6% | $1.22 | $1.26 | $1.19 | 111,805 | |
| $1.24 | +0.03 | +2.5% | $1.22 | $1.26 | $1.20 | 58,537 | |
| $1.21 | 0.00 | 0.0% | $1.23 | $1.29 | $1.16 | 161,564 | |
| $1.21 | -0.01 | -0.8% | $1.25 | $1.27 | $1.19 | 184,723 | |
| $1.22 | +0.05 | +4.3% | $1.19 | $1.22 | $1.14 | 58,227 | |
| $1.17 | -0.11 | -8.6% | $1.28 | $1.28 | $1.17 | 68,656 | |
| $1.28 | +0.05 | +4.1% | $1.25 | $1.33 | $1.23 | 134,955 | |
| $1.23 | +0.11 | +9.8% | $1.13 | $1.24 | $1.12 | 109,491 | |
| $1.12 | -0.02 | -1.8% | $1.18 | $1.20 | $1.12 | 195,300 | |
| $1.14 | -0.05 | -4.2% | $1.19 | $1.28 | $1.12 | 341,330 | |
| $1.19 | +0.01 | +0.8% | $1.21 | $1.27 | $1.15 | 382,262 | |
| $1.18 | -0.21 | -15.1% | $1.44 | $1.465 | $1.15 | 395,536 | |
| $1.39 | -0.04 | -2.8% | $1.55 | $1.60 | $1.36 | 539,388 | |
| $1.43 | -0.02 | -1.4% | $1.45 | $1.47 | $1.40 | 186,138 | |
| $1.45 | +0.05 | +3.6% | $1.41 | $1.49 | $1.37 | 91,480 | |
| $1.40 | -0.11 | -7.3% | $1.57 | $1.57 | $1.34 | 169,697 | |
| $1.51 | 0.00 | 0.0% | $1.55 | $1.62 | $1.47 | 42,570 | |
| $1.51 | -0.16 | -9.6% | $1.66 | $1.729 | $1.46 | 219,434 | |
| $1.67 | -0.11 | -6.2% | $1.79 | $1.79 | $1.67 | 60,681 | |
| $1.78 | -0.09 | -4.8% | $1.95 | $1.975 | $1.78 | 48,039 | |
| $1.87 | +0.03 | +1.6% | $1.87 | $1.87 | $1.82 | 30,182 | |
| $1.84 | +0.02 | +1.1% | $1.92 | $1.92 | $1.82 | 74,864 | |
| $1.82 | -0.01 | -0.5% | $1.98 | $1.98 | $1.806 | 86,034 | |
| $1.83 | +0.03 | +1.7% | $1.80 | $1.89 | $1.80 | 65,015 | |
| $1.80 | -0.275 | -13.3% | $2.07 | $2.09 | $1.80 | 124,577 | |
| $2.075 | -0.015 | -0.7% | $2.13 | $2.15 | $1.96 | 55,486 | |
| $2.09 | -0.14 | -6.3% | $2.25 | $2.309 | $2.06 | 72,943 | |
| $2.23 | -0.12 | -5.1% | $2.36 | $2.37 | $2.174 | 161,240 | |
| $2.35 | -0.03 | -1.3% | $2.37 | $2.42 | $2.35 | 50,009 | |
| $2.38 | -0.02 | -0.8% | $2.39 | $2.44 | $2.37 | 73,555 | |
| $2.40 | +0.05 | +2.1% | $2.37 | $2.44 | $2.37 | 71,669 | |
| $2.35 | +0.03 | +1.3% | $2.32 | $2.39 | $2.32 | 73,034 | |
| $2.32 | +0.01 | +0.4% | $2.31 | $2.34 | $2.28 | 33,372 | |
| $2.31 | 0.00 | 0.0% | $2.33 | $2.45 | $2.29 | 65,748 | |
| $2.31 | -0.06 | -2.5% | $2.35 | $2.40 | $2.31 | 38,394 | |
| $2.37 | +0.005 | +0.2% | $2.35 | $2.40 | $2.35 | 18,894 | |
| $2.365 | -0.045 | -1.9% | $2.41 | $2.45 | $2.35 | 44,376 | |
| $2.41 | +0.04 | +1.7% | $2.46 | $2.47 | $2.375 | 27,557 | |
| $2.37 | +0.02 | +0.9% | $2.33 | $2.40 | $2.33 | 26,575 | |
| $2.35 | -0.08 | -3.3% | $2.39 | $2.44 | $2.34 | 70,008 | |
| $2.43 | -0.03 | -1.2% | $2.46 | $2.50 | $2.42 | 48,766 | |
| $2.46 | -0.05 | -2.0% | $2.48 | $2.54 | $2.45 | 46,427 | |
| $2.51 | -0.02 | -0.8% | $2.52 | $2.55 | $2.49 | 17,294 | |
| $2.53 | -0.01 | -0.4% | $2.55 | $2.55 | $2.51 | 23,836 | |
| $2.54 | 0.00 | 0.0% | $2.57 | $2.57 | $2.52 | 10,321 | |
| $2.54 | 0.00 | 0.0% | $2.46 | $2.59 | $2.46 | 13,202 | |
| $2.54 | +0.02 | +0.8% | $2.59 | $2.60 | $2.50 | 16,671 | |
| $2.52 | -0.07 | -2.7% | $2.56 | $2.59 | $2.50 | 23,171 | |
| $2.59 | 0.00 | 0.0% | $2.60 | $2.60 | $2.50 | 26,653 | |
| $2.59 | -0.03 | -1.1% | $2.62 | $2.62 | $2.50 | 32,803 | |
| $2.62 | +0.03 | +1.2% | $2.61 | $2.70 | $2.61 | 56,240 | |
| $2.59 | +0.03 | +1.2% | $2.51 | $2.60 | $2.51 | 31,344 | |
| $2.56 | -0.04 | -1.5% | $2.63 | $2.66 | $2.56 | 51,051 | |
| $2.60 | +0.12 | +4.8% | $2.50 | $2.636 | $2.50 | 46,622 | |
| $2.48 | -0.12 | -4.6% | $2.51 | $2.64 | $2.45 | 30,388 | |
| $2.60 | -0.04 | -1.5% | $2.57 | $2.63 | $2.57 | 27,991 | |
| $2.64 | +0.04 | +1.5% | $2.57 | $2.65 | $2.552 | 20,552 | |
| $2.60 | +0.03 | +1.2% | $2.61 | $2.61 | $2.56 | 31,899 | |
| $2.57 | +0.05 | +2.0% | $2.52 | $2.59 | $2.49 | 16,081 | |
| $2.52 | 0.00 | 0.0% | $2.47 | $2.63 | $2.47 | 18,524 | |
| $2.52 | -0.04 | -1.6% | $2.66 | $2.66 | $2.485 | 24,405 | |
| $2.56 | -0.10 | -3.8% | $2.70 | $2.70 | $2.53 | 38,806 | |
| $2.66 | +0.09 | +3.5% | $2.60 | $2.67 | $2.55 | 47,961 | |
| $2.57 | +0.04 | +1.6% | $2.60 | $2.69 | $2.51 | 129,327 | |
| $2.53 | +0.05 | +2.0% | $2.607 | $2.607 | $2.475 | 30,267 |
- Ticker
- Munich:NV40
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Nov 2, 2026
Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Tuesday, November 10, 2026
Latest earnings call · Aug 13, 2026
Cellectar Biosciences (NASDAQ:CLRB) Q2 2026 Earnings Call
Replay and transcript
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 41 slides
Calls
Upcoming
Cellectar Biosciences (NASDAQ:CLRB) Q3 2026 Earnings Call
Tue, Nov 10, 2026 · 8:30 AM ET
Register
Replays
Cellectar Biosciences (NASDAQ:CLRB) Q2 2026 Earnings Call
Thu, Aug 13, 2026 · 8:30 AM ET
Watch TranscriptCellectar Biosciences (NASDAQ:CLRB) Q1 2026 Earnings Call
Thu, May 14, 2026 · 8:30 AM ET
Watch TranscriptCellectar Biosciences (NASDAQ:CLRB) Q4 2025 Earnings Call
Wed, Mar 04, 2026 · 8:30 AM ET
Watch Transcript
Latest news
Cellectar Biosciences Reports Case Study Highlighting Complete Response Lasting More Than Eight Years in Heavily Pretreated DLBCL Patient Treated with Iopofosine I 131
Oct 27, 2026
Closed $1.21 (0.0%) on Oct 27, 2026
Cellectar Biosciences Presents Compelling Efficacy Data from Phase 2b CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Relapsed/Refractory to BTK Inhibitor Therapy at the International Workshop for Waldenström Macroglobulinemia
Oct 15, 2026
Closed $1.19 (+0.8%) on Oct 15, 2026
Cellectar Biosciences to Present Compelling Efficacy Data from Phase 2 CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Refractory/Resistant to BTK Inhibitor Therapy at International Workshop for Waldenström Macroglobulinemia
Sep 29, 2026
Closed $1.82 (-0.5%) on Sep 29, 2026
Cellectar Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
Aug 13, 2026
Closed $2.48 (-4.6%) on Aug 13, 2026
Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026
Jul 30, 2026
Closed $2.53 (+2.0%) on Jul 30, 2026
Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers
Jul 15, 2026
Closed $2.61 (-0.8%) on Jul 15, 2026
Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting
Jun 1, 2026
Closed $2.97 (-5.4%) on Jun 1, 2026
Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 14, 2026
Closed $3.20 (+8.8%) on May 14, 2026
Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026
May 11, 2026
Closed $3.06 (-1.3%) on May 11, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 41 slides · October 2026
Investor Presentation (October 2026)
Investor deck · 39 slides · October 2026
Investor Presentation (October 2026)
Investor deck · 38 slides · October 2026
Q2 2026 Earnings Presentation
Earnings · 38 slides · Aug 13, 2026
Cellectar Biosciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 20 in the last 12 months · 162 in all · newest Nov 2, 2026 · oldest 2019
- Calls
- 12 calls with a replay · 12 with a transcript · latest Aug 13, 2026
- Decks
- 25 decks · latest October 2026
Where Cellectar Biosciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CLRB · Home listing | NASDAQ | United States | USD |
| BOATS:CLRB | BOATS | United States | USD |
| gettex:NV40 | gettex | Germany | EUR |
| LS Exchange:A41BQ3 | LS Exchange | Germany | EUR |
| Frankfurt:NV40 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A41BQ3 | Lang & Schwarz | Germany | EUR |
| Munich:NV40 · This page | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Cellectar Biosciences, Inc.